FDA’s Office of International Programs (OIP) coordinates and facilitates the Agency’s Capacity Building Program which includes technical cooperation and assistance efforts. CBER partners with OIP in many of those activities, but also leads the effort in regulatory capacity building for regulated products specific to CBER.
via Whats New Vaccines Blood Biologics RSS Feed http://bit.ly/2I7EGob
No comments:
Post a Comment